• Je něco špatně v tomto záznamu ?

Sarcopenia: revised European consensus on definition and diagnosis

AJ. Cruz-Jentoft, G. Bahat, J. Bauer, Y. Boirie, O. Bruyère, T. Cederholm, C. Cooper, F. Landi, Y. Rolland, AA. Sayer, SM. Schneider, CC. Sieber, E. Topinkova, M. Vandewoude, M. Visser, M. Zamboni, Writing Group for the European Working Group on...

. 2019 ; 48 (1) : 16-31. [pub] 20190101

Jazyk angličtina Země Velká Británie

Typ dokumentu konsensus - konference, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006760

Grantová podpora
MC_UP_A620_1015 Medical Research Council - United Kingdom
MC_U147585827 Medical Research Council - United Kingdom
MC_UU_12011/2 Medical Research Council - United Kingdom
MC_U147585819 Medical Research Council - United Kingdom
MC_UP_A620_1014 Medical Research Council - United Kingdom
G0601019 Medical Research Council - United Kingdom
G0400491 Medical Research Council - United Kingdom
MC_U147585824 Medical Research Council - United Kingdom
10/33/04 Department of Health - United Kingdom
MC_UU_12011/1 Medical Research Council - United Kingdom

Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.

Amsterdam The Netherlands

Center for Geriatric Medicine University Heidelberg Agaplesion Bethanien Krankenhaus Heidelberg Germany

Department Geriatrics University of Antwerp Ziekenhuisnetwerk Antwerpen Antwerp Belgium

Department of Epidemiology University of Oxford OX UK

Department of Gastroenterology and Clinical Nutrition Centre Hospitalier Universitaire de Nice Université Côte d'Azur Nice France

Department of Geriatrics 1st Faculty of Medicine Charles University and General Faculty Hospital Prague Czech Republic

Department of Geriatrics Hospital and University of Toulouse Toulouse France

Department of Health Sciences Faculty of Science Vrije Universiteit Amsterdam

Department of Internal Medicine Division of Geriatrics Istanbul Medical School Istanbul University Istanbul Turkey

Department of Internal Medicine Geriatrics Institute for Biomedicine and Ageing Friedrich Alexander University Erlangen Nürnberg Germany

Department of Medicine Geriatric section University of Verona Verona Italy

Department of Public Health and Caring Sciences Clinical Nutrition and Metabolism Uppsala University Uppsala and Theme Ageing Karolinska University Hospital Stockholm Sweden

Department of Public Health Epidemiology and Health Economics University of Liège Liège Belgium

Instituto di Medicina Interna e Geriatria Università Cattolica del Sacro Cuore Roma Italy

MRC Lifecourse Epidemiology Unit University of Southampton

NIHR Newcastle Biomedical Research Centre Newcastle upon Tyne Hospitals NHS Foundation Trust and Faculty of Medical Sciences Newcastle University Newcastle UK

Research Department Centre Hospitalier Universitaire de Clermont Ferrand Clermont Ferrand France

Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid Spain

Southampton UK

the Amsterdam Public Health Research Institute

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006760
003      
CZ-PrNML
005      
20200525092140.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ageing/afy169 $2 doi
035    __
$a (PubMed)30312372
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Cruz-Jentoft, Alfonso J $u Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
245    10
$a Sarcopenia: revised European consensus on definition and diagnosis / $c AJ. Cruz-Jentoft, G. Bahat, J. Bauer, Y. Boirie, O. Bruyère, T. Cederholm, C. Cooper, F. Landi, Y. Rolland, AA. Sayer, SM. Schneider, CC. Sieber, E. Topinkova, M. Vandewoude, M. Visser, M. Zamboni, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2,
520    9_
$a Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
650    _2
$a biologické markery $7 D015415
650    _2
$a biomedicínský výzkum $7 D035843
650    _2
$a lidé $7 D006801
650    _2
$a svalová síla $7 D053580
650    _2
$a kosterní svaly $x diagnostické zobrazování $x patologie $7 D018482
650    _2
$a sarkopenie $x diagnóza $x ekonomika $x terapie $7 D055948
651    _2
$a Evropa $7 D005060
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bahat, Gülistan $u Department of Internal Medicine, Division of Geriatrics, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
700    1_
$a Bauer, Jürgen $u Center for Geriatric Medicine, University Heidelberg, Agaplesion Bethanien Krankenhaus, Heidelberg, Germany.
700    1_
$a Boirie, Yves $u Research Department, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
700    1_
$a Bruyère, Olivier $u Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
700    1_
$a Cederholm, Tommy $u Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, and Theme Ageing, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Cooper, Cyrus $u MRC Lifecourse Epidemiology Unit, University of Southampton; Southampton, UK; and Department of Epidemiology, University of Oxford, OX, UK.
700    1_
$a Landi, Francesco $u Instituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Roma, Italy.
700    1_
$a Rolland, Yves $u Department of Geriatrics, Hospital and University of Toulouse, Toulouse, France.
700    1_
$a Sayer, Avan Aihie $u NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
700    1_
$a Schneider, Stéphane M $u Department of Gastroenterology and Clinical Nutrition, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
700    1_
$a Sieber, Cornel C $u Department of Internal Medicine-Geriatrics, Institute for Biomedicine and Ageing, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany.
700    1_
$a Topinkova, Eva $u Department of Geriatrics, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
700    1_
$a Vandewoude, Maurits $u Department Geriatrics, University of Antwerp, Ziekenhuisnetwerk Antwerpen (ZNA), Antwerp, Belgium.
700    1_
$a Visser, Marjolein $u Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam; and the Amsterdam Public Health Research Institute; Amsterdam, The Netherlands.
700    1_
$a Zamboni, Mauro $u Department of Medicine, Geriatric section, University of Verona, Verona, Italy.
710    2_
$a Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2
773    0_
$w MED00000173 $t Age and ageing $x 1468-2834 $g Roč. 48, č. 1 (2019), s. 16-31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30312372 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200525092140 $b ABA008
999    __
$a ok $b bmc $g 1525618 $s 1096816
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 48 $c 1 $d 16-31 $e 20190101 $i 1468-2834 $m Age and ageing $n Age Ageing $x MED00000173
GRA    __
$a MC_UP_A620_1015 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_U147585827 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_UU_12011/2 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_U147585819 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_UP_A620_1014 $p Medical Research Council $2 United Kingdom
GRA    __
$a G0601019 $p Medical Research Council $2 United Kingdom
GRA    __
$a G0400491 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_U147585824 $p Medical Research Council $2 United Kingdom
GRA    __
$a 10/33/04 $p Department of Health $2 United Kingdom
GRA    __
$a MC_UU_12011/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace